Below is a list of all work bearing my name that has been published or self-published, comprising firstly my non-fiction and fiction; then my professional science work (which should really come first).

Unless noted, all are available in print from Lulu or Amazon, and as e-books on Kindle and possibly other formats.

NON-FICTION

Traditionally published books

Alderley Park Discovered: Wildlife, History, Pharmaceuticals (Carnegie Publishing, 31st March 2016, 378 pages, c400 colour images, £30.) [Not available electronically].

Self-published books on science and faith

Discovering Jesus In a Chemistry Lab: 52 Reflections from a Bench (2017).

Adam, Eden, Evolution and Three Men: Debate in a Boat (2017).

Self-published books on travel and climate

Island Collecting: 111 Ways to Downcarbon (2019).

FICTION

Self-published novels

The Song of Rockall (2013)

A Nest on Lifandoy (2013)

An Orchid on Lifandoy (2013)

Falcons Over Lifandoy (2014)

Night Birds off Lifandoy (2017)

Nevaeh's Salt (To Search the New Earth) (2021)

ENVIRONMENTAL

Non-public-domain publications

1. Alderley Park and Radnor Mere Bird/Wildlife Report - editor and major writer, 1978-2011.

2. Alderley Park History and Nature Trail guides (black and white first edition):

"Red Route" guide: Radnor Mere and Beech Wood (1988, grey then red cover);

"Blue Route" guide: Water Garden & Alderley House (1990, blue cover);

- these were then superseded by:

3. Alderley Park History and Nature Trail guides (colour second edition extended set):

"Blue Route" guide: Water Garden and Serpentine (2003);

"Purple Route" guide: Parkland and Old Buildings (2003);

"Gold Route" guide: Ice House and Trees Walk (2003);

"Red Route" guide: Radnor Mere and Beech Wood (2005);

"Green Route" guide: Parkland and Woodland (2005)

Internet self-publications

1. A eulogy to the denizens of Chelford Railway Station (Chelford Village Website, 2007)

2. Seen Cycling to Work (Chelford Village Website, 2007)

Internet group self- publications

1. Sandbach Environment Trail (Sandbach A Rocha group, 2008)

2. Brook Wood to Wheelock Trail) (Sandbach Woodland and Wildlife Group, 2015)

3. Dingle Wood Trail (Sandbach Woodland and Wildlife Group, 2017)

POETRY

The Hundred-eyed Hunter (Bird News, newsletter of the Cheshire & Wirral Ornithological Soc., Jul 2013)

From the Street (Displayed on the wall of a youth homeless shelter in Birmingham, UK. I need nothing more.)

CHILDREN'S FICTION

Mr Elephant's Good News (Sandbach Evangelical Church Magazine, 1995)

PROFESSIONAL SCIENCE WORK

It is hugely important to say that most of my professional science work was, of course, the output of great teams in which I played only a small role. Only ones with * against my name were with me as lead or sole author; others were as a named author only and were not written by me.

Publications

1. Tricyclic triarylethylene antiestrogens: dibenz[b,f]oxepins, dibenzo[b,f]thiepins, dibenzo[a,e]cyclooctenes, and dibenzo[b,f]thiocins. D. Acton, G. Hill, B. S. Tait*. J. Med. Chem. 1983, 26, 8, 1131-7.

2. Approaches to the design of anti-fibrotic drugs. T. J. Franklin*, N. J. Hales, D. Johnstone, W. B. Morris, J. C. Cunliffe, A. J. Millest, G. B. Hill. Biochem. Soc. Trans. 1991, 19, 4, 812-15.

3. Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analog N-oxaloglycine and its derivatives. J. C. Cunliffe; T. J. Franklin, N. J. Hales, G. B. Hill. J. Med. Chem. 1992, 35, 14, 2652-8.

4. Valuable synthetic building blocks: Useful 2-substituted 5-aminopyrimidines from a stable precursor. C. B. Dousson, N. M. Heron, G. B. Hill*. Synthesis 2005, 11, 1817-1821.

5. Discovery of Novel and Potent Thiazoloquinazolines as Selective Aurora A and B Kinase Inhibitors. F. H. Jung*, G. Pasquet, C. L. Van der Brempt, J-J. M. Lohmann, N. Warin, F. Renaud, H. Germain, C. De Savi, N. Roberts, T. Johnson, C. Dousson, G. B. Hill, A. A. Mortlock, N. Heron, R. W. Wilkinson, S. R. Wedge, S. P. Heaton, R. Odedra, N. J. Keen, S. Green, E. Brown, K. Thompson, S. Brightwell, J. Med. Chem. 2006, 49, 3, 955-70.

6. SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors. N. M. Heron*, M. Anderson, D. P. Blowers, J. Breed, J. M. Eden, S. Green, G. B. Hill, T. Johnson, F. H. Jung, H. H. McMiken, A. A. Mortlock, A. D. Pannifer, R. A. Pauptit, J. Pink, N. J. Roberts, S. Rowsell. Bioorg. & Med. Chem. Lett. 2006, 16, 5, 1320-1323. [This paper received the award for Most Cited Paper in the journal for 2006-2009].

7. Discovery, Synthesis, and in Vivo Activity of a New Class of Pyrazolylquinazolines as Selective Inhibitors of Aurora B Kinase. A. A. Mortlock, K. M. Foote*, N. M. Heron, F. H. Jung, G. Pasquet, J-J. M. Lohmann, N. Warin, F. Renaud, C. De Savi, N. J. Roberts, T. Johnson, C. B. Dousson, G. B. Hill, D. Perkins, G. Hatter, R. W. Wilkinson, S. R. Wedge, S. P. Heaton, R. Odedra, N. J. Keen, C. Crafter, E. Brown, K. Thompson, S. Brightwell, L. Khatri, M. C. Brady, S. Kearney, D. McKillop, S. Rhead, T. Parry, S. Green. J. Med. Chem. 2007, 50, 9, 2213-2224.

8. Two new syntheses of a 4-aminopyrazole: condensation of an N-substituted vinamidinium salt with a functionalized hydrazine. G. B. Hill*, A. A. Mortlock. Synthesis 2007, 11, 1697-1701.

9. Synthesis and SAR of 1-acetanilide-4-aminopyrazole substituted quinazolines: Selective inhibitors of Aurora B kinase with potent antitumor activity. K. M. Foote*, A. A. Mortlock, N. M. Heron, F. H. Jung, G. B. Hill, G. Pasquet, M. C. Brady, S. Green, S. P. Heaton, S. Kearney, N. J. Keen, R. Odedra, S. R. Wedge, and R. W. Wilkinson. Bioorg. & Med. Chem. Lett. 2008, 18, 1904-1909.

10. Structure- and Reactivity-Based Development of Covalent Inhibitors of the Activating and Gatekeeper Mutant Forms of the Epidermal Growth Factor Receptor (EGFR). Richard A. Ward,* Mark J. Anderton, Susan Ashton, Paul A. Bethel, Matthew Box, Sam Butterworth, Nicola Colclough, Christopher G. Chorley, Claudio Chuaqui, Darren A. E. Cross, Les A. Dakin, Judit É. Debreczeni, Cath Eberlein, M. Raymond V. Finlay, George B. Hill, Matthew Grist, Teresa C. M. Klinowska, Clare Lane, Scott Martin, Jonathon P. Orme, Peter Smith,‡ Fengjiang Wang, and Michael J. Waring. J. Med. Chem. 2013, 56, 7025−7048.

11. The Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitising and T790M resistance mutations that spares the wild type form of the receptor. Finlay, M. Raymond; Anderton, Mark; Ashton, Susan; Ballard, Peter; Bethel, Paul; Box, Matthew; Bradbury, Robert; Brown, Simon; Butterworth, Sam; Campbell, Andrew; Chorley, Christopher; Colclough, Nicola; Cross, Darren; Currie, Gordon; Grist, Matthew; Hassall, Lorraine; Hill, George; James, Daniel; James, Michael; Kemmitt, Paul; Klinowska, Teresa; Lamont, Gillian; Lamont, Scott; Martin, Nathaniel; McFarland, Heather; Mellor, Martine; Orme, Jonathon; Perkins, David; Perkins, Paula; Richmond, Graham; Smith, Peter; Ward, Richard; Waring, Michael; Whittaker, David; Wells, Stuart; Wrigley, Gail. J. Med. Chem., 2014, 57, 8249-8267.

12. Reaction Workup Planning: A Structured Flowchart Approach, Exemplified in Difficult Aqueous Workup of Hydrophilic Products. George B. Hill*, Joseph B. Sweeney*. J. Chem. Educ., 2015, 92, 488-496.

Patents

1. Phenol derivatives. G. C. Crawley, P. N. Edwards, G. B. Hill, W. R. Pilgrim, B. S. Tait, D. W. Young. Patent No. EP124369 A1; 127pp; Dated: 27.04.1984. Filed in UK.

2. Process for preparation of 4-aminopyrazole derivatives. G. B. Hill*. Patent No. 2007/034183 A2; 27pp; Dated: 29.03.2007. Filed in UK.

3. Pyrimidine derivatives as antiproliferative agents and their preparation, pharmaceutical compositions and use in the treatment of diseases. Butterworth, S.; Griffen, E. J.; Hill, G. B.; P., Martin. From PCT Int. Appl. (2008), WO 2008032027.

4. Preparation of 6-benzimidazolyl-2-morpholino-4-(azetidine, pyrrolidine, piperidine, or azepine) pyrimidine derivatives as PI3K and mTOR kinase inhibitors for the treatment of proliferative disorders. Butterworth, S.; Griffen, E. J.; Hill, G. B; Pass, M. From PCT Int. Appl. (2008), WO 2008032036.

5. Preparation of 4-benzimidazolyl-2-morpholino-6-piperazinyl-pyrimidine derivatives as PI3K and mTOR kinase inhibitors for the treatment of proliferative disorder. Butterworth, S; G, E Jolyon; Hill, G. B; Pass, M. From PCT Int. Appl. (2008), WO 20080320331. .

6. Preparation of 4-benzimidazolyl-2-morpholino-6-piperidinyl-4-pyrimidine derivatives as PI3K and mTOR kinase inhibitors for the treatment of proliferative disorder. Butterworth, S; Griffen, E. J.; Hill, G. B.; Pass, M.. From PCT Int. Appl. (2008), WO 2008032089.